Bio-Gene Technology Ltd. (AU:BGT) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Bio-Gene Technology Ltd. has announced the cessation of 2.5 million options due to the expiry on May 6, 2024. These options, under the code BGTAK, were not exercised or converted by their expiration date. The company provided this update in a recent filing, underscoring a change in its issued capital structure.
For further insights into AU:BGT stock, check out TipRanks’ Stock Analysis page.